Related Experiment Video
Updated: Aug 6, 2026
07:48
An Orthotopic Bladder Cancer Model for Gene Delivery Studies
Published on: December 1, 2013
Recent advances in intravesical drug/gene delivery
Pradeep Tyagi1, Pao-Chu Wu, Michael Chancellor
1Department of Urology, University of Pittsburgh, Pittsburgh, Pennsylvania 15213, USA.
Molecular Pharmaceutics
|August 8, 2006
Summary
Intravesical drug delivery (IDD) offers targeted bladder treatment by exploiting anatomy, overcoming systemic limitations. This review examines IDD
Area of Science:
- Urology
- Pharmacology
- Biomedical Engineering
Background:
- Systemic drug targeting relies on receptor affinity.
- Bladder drug delivery is simplified by anatomical targeting.
- Intravesical drug delivery (IDD) utilizes pelvic anatomy for regional therapy.
Purpose of the Study:
- Discuss limitations of current intravesical drug delivery (IDD) methods.
- Explore future developments in bladder-specific drug administration.
- Highlight IDD advantages in superficial bladder cancer chemotherapy and neurogenic bladder treatment.
Main Methods:
- Review of existing literature on intravesical drug delivery.
- Analysis of anatomical advantages for targeted bladder therapy.
- Examination of DNA/transgene delivery via the intravesical route.
Main Results:
- Intravesical administration is effective for bladder cancer chemotherapy.
- The intravesical route is used for neurogenic bladder treatment.
- Transgene expression can be confined to the bladder using IDD.
Conclusions:
- IDD offers a promising approach for targeted bladder treatments.
- Current IDD methods have limitations that require further research.
- Future developments in IDD could enhance treatment efficacy and reduce side effects.
Related Concept Videos
00:59Gene Therapy
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be inserted. The...
01:29Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.